Bio2Business: Company Profile Header

CARBOGEN AMCIS

CARBOGEN AMCIS leverages its world-class chemistry skills to provide seamless drug substance, drug products development and commercialization services for leading pharmaceutical and biopharmaceutical companies. We help customers create a better world by becoming the partner of choice thanks to our innovative solutions. We offer an array of integrated and customized services operating in a fully cGMP-compliant infrastructure, including dedicated Highly Potent API facilities and a clean room for Antibody Drug Conjugates. Beyond our services, we also provide high-quality Cholesterol and Vitamin D analogs. CARBOGEN AMCIS is owned by Dishman Carbogen Amcis Limited, (India).
Learn more about us: www.carbogen-amcis.com

Categories

Meet the Team


BOS Basel 2022 Presentation

8th June, 16.00 - 16.30

Discovery & Development of a New ADC - CARBOGEN AMCIS & Heidelberg Pharma Formula for Successful Collaboration

Dr Christian Lutz, Director Project Management CMC, Heidelberg Pharma Research GmbH
Thomas Schlatterer, Head of Sales, CARBOGEN AMCIS AG